لیراگلوتاید (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "لیراگلوتاید" in Persian language version.

refsWebsite

Global rank Persian rank

9nih.gov

4^th place

5^th place

7worldcat.org

5^th place

12^th place

7doi.org

2^nd place

1webmd.com

1,169^th place

175^th place

1bmj.com

1,226^th place

869^th place

1drugdevelopment-technology.com

low place

1medicalnewstoday.com

3,011^th place

459^th place

1diabetesjournals.org

low place

1web.archive.org

1^st place

1novonordisk-us.com

low place

1clinicaltrials.gov

5,225^th place

5,710^th place

1fda.gov

447^th place

382^nd place

1jamanetwork.com

2,650^th place

2,401^st place

1nejm.org

2,374^th place

2,531^st place

1drugs.com

399^th place

104^th place

bmj.com

Liu, Jiali; Li, Ling; Deng, Ke; Xu, Chang; Busse, Jason W.; Vandvik, Per Olav; Li, Sheyu; Guyatt, Gordon H.; Sun, Xin (2017-06-08). "Incretin based treatments and mortality in patients with type 2 diabetes: systematic review and meta-analysis". BMJ (به انگلیسی). 357: j2499. doi:10.1136/bmj.j2499. ISSN 0959-8138. PMC 5463186. PMID 28596247.{{cite journal}}: نگهداری یادکرد:فرمت پارامتر PMC (link)

clinicaltrials.gov

"Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes - Full Text View - ClinicalTrials.gov" (به انگلیسی). Retrieved 2018-11-18.

diabetesjournals.org

care.diabetesjournals.org

Nauck, Michael; Frid, Anders; Hermansen, Kjeld; Shah, Nalini S.; Tankova, Tsvetalina; Mitha, Ismail H.; Zdravkovic, Milan; Düring, Maria; Matthews, David R. (2009-01-01). "Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: The LEAD (Liraglutide Effect and Action in Diabetes)-2 study". Diabetes Care (به انگلیسی). 32 (1): 84–90. doi:10.2337/dc08-1355. ISSN 0149-5992. PMID 18931095.

doi.org

Beglinger, Christoph; Degen, Lukas (2006-11-30). "Gastrointestinal satiety signals in humans--physiologic roles for GLP-1 and PYY?". Physiology & Behavior. 89 (4): 460–464. doi:10.1016/j.physbeh.2006.05.048. ISSN 0031-9384. PMID 16828127.
Liu, Jiali; Li, Ling; Deng, Ke; Xu, Chang; Busse, Jason W.; Vandvik, Per Olav; Li, Sheyu; Guyatt, Gordon H.; Sun, Xin (2017-06-08). "Incretin based treatments and mortality in patients with type 2 diabetes: systematic review and meta-analysis". BMJ (به انگلیسی). 357: j2499. doi:10.1136/bmj.j2499. ISSN 0959-8138. PMC 5463186. PMID 28596247.{{cite journal}}: نگهداری یادکرد:فرمت پارامتر PMC (link)
Nauck, Michael; Frid, Anders; Hermansen, Kjeld; Shah, Nalini S.; Tankova, Tsvetalina; Mitha, Ismail H.; Zdravkovic, Milan; Düring, Maria; Matthews, David R. (2009-01-01). "Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: The LEAD (Liraglutide Effect and Action in Diabetes)-2 study". Diabetes Care (به انگلیسی). 32 (1): 84–90. doi:10.2337/dc08-1355. ISSN 0149-5992. PMID 18931095.
Parks, Mary; Rosebraugh, Curtis (2010-03-04). "Weighing Risks and Benefits of Liraglutide — The FDA's Review of a New Antidiabetic Therapy". New England Journal of Medicine. 362 (9): 774–777. doi:10.1056/nejmp1001578. ISSN 0028-4793.
Singh, Sonal; Chang, Hsien-Yen; Richards, Thomas M.; Weiner, Jonathan P.; Clark, Jeanne M.; Segal, Jodi B. (2013-04-08). "Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus". JAMA Internal Medicine (به انگلیسی). 173 (7): 534. doi:10.1001/jamainternmed.2013.2720. ISSN 2168-6106.
Egan, Amy G.; Blind, Eberhard; Dunder, Kristina; de Graeff, Pieter A.; Hummer, B. Timothy; Bourcier, Todd; Rosebraugh, Curtis (2014-02-27). "Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment". New England Journal of Medicine (به انگلیسی). 370 (9): 794–797. doi:10.1056/nejmp1314078. ISSN 0028-4793.

dx.doi.org

Parks, Mary; Rosebraugh, Curtis (2010-03-04). "Weighing Risks and Benefits of Liraglutide — The FDA's Review of a New Antidiabetic Therapy". New England Journal of Medicine. 362 (9): 774–777. doi:10.1056/nejmp1001578. ISSN 0028-4793.

drugdevelopment-technology.com

«Liraglutide – Next-Generation Antidiabetic Medication - Drug Development Technology» (به انگلیسی). Drug Development Technology. دریافت‌شده در ۲۰۱۸-۱۱-۱۸.

drugs.com

«Novo Nordisk Files for Regulatory Approval of Liraglutide in Both the US and Europe» (به انگلیسی). Drugs.com. دریافت‌شده در ۲۰۱۸-۱۱-۱۸. کاراکتر line feed character در |عنوان= در موقعیت 66 (کمک)

fda.gov

accessdata.fda.gov

FDA. "HIGHLIGHTS OF VICTOZA PRESCRIBING INFORMATION" (PDF) (به انگلیسی).

jamanetwork.com

Singh, Sonal; Chang, Hsien-Yen; Richards, Thomas M.; Weiner, Jonathan P.; Clark, Jeanne M.; Segal, Jodi B. (2013-04-08). "Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus". JAMA Internal Medicine (به انگلیسی). 173 (7): 534. doi:10.1001/jamainternmed.2013.2720. ISSN 2168-6106.

medicalnewstoday.com

"Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, And Blood Pressure In Patients With Type 2 Diabetes" (به انگلیسی). Retrieved 2018-11-18.

nejm.org

Egan, Amy G.; Blind, Eberhard; Dunder, Kristina; de Graeff, Pieter A.; Hummer, B. Timothy; Bourcier, Todd; Rosebraugh, Curtis (2014-02-27). "Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment". New England Journal of Medicine (به انگلیسی). 370 (9): 794–797. doi:10.1056/nejmp1314078. ISSN 0028-4793.

nih.gov

dailymed.nlm.nih.gov

"Victoza- liraglutide injection". DailyMed. Retrieved 5 June 2021.
"Saxenda- liraglutide injection, solution". DailyMed. Retrieved 5 June 2021.
"Saxenda- liraglutide injection, solution". DailyMed. Retrieved 5 June 2021.
"Saxenda- liraglutide injection, solution". DailyMed. Retrieved 5 June 2021.

pubmed.ncbi.nlm.nih.gov

Beglinger, Christoph; Degen, Lukas (2006-11-30). "Gastrointestinal satiety signals in humans--physiologic roles for GLP-1 and PYY?". Physiology & Behavior. 89 (4): 460–464. doi:10.1016/j.physbeh.2006.05.048. ISSN 0031-9384. PMID 16828127.
Liu, Jiali; Li, Ling; Deng, Ke; Xu, Chang; Busse, Jason W.; Vandvik, Per Olav; Li, Sheyu; Guyatt, Gordon H.; Sun, Xin (2017-06-08). "Incretin based treatments and mortality in patients with type 2 diabetes: systematic review and meta-analysis". BMJ (به انگلیسی). 357: j2499. doi:10.1136/bmj.j2499. ISSN 0959-8138. PMC 5463186. PMID 28596247.{{cite journal}}: نگهداری یادکرد:فرمت پارامتر PMC (link)
Nauck, Michael; Frid, Anders; Hermansen, Kjeld; Shah, Nalini S.; Tankova, Tsvetalina; Mitha, Ismail H.; Zdravkovic, Milan; Düring, Maria; Matthews, David R. (2009-01-01). "Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: The LEAD (Liraglutide Effect and Action in Diabetes)-2 study". Diabetes Care (به انگلیسی). 32 (1): 84–90. doi:10.2337/dc08-1355. ISSN 0149-5992. PMID 18931095.

ncbi.nlm.nih.gov

Beglinger, Christoph; Degen, Lukas (2006-11-30). "Gastrointestinal satiety signals in humans--physiologic roles for GLP-1 and PYY?". Physiology & Behavior. 89 (4): 460–464. doi:10.1016/j.physbeh.2006.05.048. ISSN 0031-9384. PMID 16828127.
Liu, Jiali; Li, Ling; Deng, Ke; Xu, Chang; Busse, Jason W.; Vandvik, Per Olav; Li, Sheyu; Guyatt, Gordon H.; Sun, Xin (2017-06-08). "Incretin based treatments and mortality in patients with type 2 diabetes: systematic review and meta-analysis". BMJ (به انگلیسی). 357: j2499. doi:10.1136/bmj.j2499. ISSN 0959-8138. PMC 5463186. PMID 28596247.{{cite journal}}: نگهداری یادکرد:فرمت پارامتر PMC (link)

novonordisk-us.com

press.novonordisk-us.com

«Novo Nordisk Receives FDA Approval of Saxenda® (liraglutide) injection 3 mg Label Update Including Long-Term Safety and Efficacy Data from 3-Year Trial». Novo Nordisk News & Media. بایگانی‌شده از اصلی در ۱۸ نوامبر ۲۰۱۸. دریافت‌شده در ۲۰۱۸-۱۱-۱۸. بیش از یک پارامتر |پیوند بایگانی= و |archiveurl= داده‌شده است (کمک); بیش از یک پارامتر |تاریخ بایگانی= و |archivedate= داده‌شده است (کمک)

web.archive.org

«Novo Nordisk Receives FDA Approval of Saxenda® (liraglutide) injection 3 mg Label Update Including Long-Term Safety and Efficacy Data from 3-Year Trial». Novo Nordisk News & Media. بایگانی‌شده از اصلی در ۱۸ نوامبر ۲۰۱۸. دریافت‌شده در ۲۰۱۸-۱۱-۱۸. بیش از یک پارامتر |پیوند بایگانی= و |archiveurl= داده‌شده است (کمک); بیش از یک پارامتر |تاریخ بایگانی= و |archivedate= داده‌شده است (کمک)

webmd.com

«New Diabetes Drug Liraglutide Works» (به انگلیسی). WebMD. دریافت‌شده در ۲۰۱۸-۱۱-۱۸.

worldcat.org

Beglinger, Christoph; Degen, Lukas (2006-11-30). "Gastrointestinal satiety signals in humans--physiologic roles for GLP-1 and PYY?". Physiology & Behavior. 89 (4): 460–464. doi:10.1016/j.physbeh.2006.05.048. ISSN 0031-9384. PMID 16828127.
Dirk.، Goldstein, Barry J. Müller-Wieland, (۲۰۰۸). Type 2 diabetes principles and practice. Informa Healthcare. OCLC 642302692. شابک ۰۸۴۹۳۷۹۵۸X.
Liu, Jiali; Li, Ling; Deng, Ke; Xu, Chang; Busse, Jason W.; Vandvik, Per Olav; Li, Sheyu; Guyatt, Gordon H.; Sun, Xin (2017-06-08). "Incretin based treatments and mortality in patients with type 2 diabetes: systematic review and meta-analysis". BMJ (به انگلیسی). 357: j2499. doi:10.1136/bmj.j2499. ISSN 0959-8138. PMC 5463186. PMID 28596247.{{cite journal}}: نگهداری یادکرد:فرمت پارامتر PMC (link)
Nauck, Michael; Frid, Anders; Hermansen, Kjeld; Shah, Nalini S.; Tankova, Tsvetalina; Mitha, Ismail H.; Zdravkovic, Milan; Düring, Maria; Matthews, David R. (2009-01-01). "Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: The LEAD (Liraglutide Effect and Action in Diabetes)-2 study". Diabetes Care (به انگلیسی). 32 (1): 84–90. doi:10.2337/dc08-1355. ISSN 0149-5992. PMID 18931095.
Parks, Mary; Rosebraugh, Curtis (2010-03-04). "Weighing Risks and Benefits of Liraglutide — The FDA's Review of a New Antidiabetic Therapy". New England Journal of Medicine. 362 (9): 774–777. doi:10.1056/nejmp1001578. ISSN 0028-4793.
Singh, Sonal; Chang, Hsien-Yen; Richards, Thomas M.; Weiner, Jonathan P.; Clark, Jeanne M.; Segal, Jodi B. (2013-04-08). "Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus". JAMA Internal Medicine (به انگلیسی). 173 (7): 534. doi:10.1001/jamainternmed.2013.2720. ISSN 2168-6106.
Egan, Amy G.; Blind, Eberhard; Dunder, Kristina; de Graeff, Pieter A.; Hummer, B. Timothy; Bourcier, Todd; Rosebraugh, Curtis (2014-02-27). "Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment". New England Journal of Medicine (به انگلیسی). 370 (9): 794–797. doi:10.1056/nejmp1314078. ISSN 0028-4793.